3-D Matrix, Ltd.

Tokyo Stock Exchange 7777.T

3-D Matrix, Ltd. EBITDA Margin for the year ending April 30, 2024: 45.59%

3-D Matrix, Ltd. EBITDA Margin is 45.59% for the year ending April 30, 2024, a 47.55% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

3-D Matrix, Ltd. EBITDA Margin for the year ending April 30, 2023 was 30.90%, a -44.79% change year over year.
3-D Matrix, Ltd. EBITDA Margin for the year ending April 30, 2022 was 55.97%, a -10.14% change year over year.
3-D Matrix, Ltd. EBITDA Margin for the year ending April 30, 2021 was 62.28%, a 174.92% change year over year.
3-D Matrix, Ltd. EBITDA Margin for the year ending April 30, 2020 was -83.13%, a 4.08% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Tokyo Stock Exchange: 7777.T

3-D Matrix, Ltd.

CEO	Mr. Jun Okada
IPO Date	Oct. 24, 2011
Location	Japan
Headquarters	Kojimachi HF Building
Employees	106
Sector	Materials
Industries Chemicals & Advanced Materials 3D Printing Biotechnology Fertilizers Robotics

Description

3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.

Key trends

Past 5 years